.[.A liquid pharmaceutical composition is disclosed comprising calcitonin
or an acid addition salt thereof and citric acid or salt thereof in a
concentration from about to about 50 mM, said composition being in a form
table for nasal administration..]. .Iadd.A liquid pharmaceutical
composition is provided for nasal administration of calcitonin or an acid
addition salt thereof. The nasal pharmaceutical formulations contain a
component selected from the group consisting of citric acid, citric acid
salt and a combination thereof..Iaddend.